Safety

Furadantin (Nitrofurantoin) Oral Suspension

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

November 2014

Summary View

ADVERSE REACTIONS

  • vasculitis

 

November 2013

Summary View

ADVERSE REACTIONS

Allergic
  • Vasculitis

 

Page Last Updated: 12/11/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.